Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Paulo Costa joins MacroGenics' board

This article was originally published in Scrip

Executive Summary

MacroGenics, a private US biotechnology company focused on the discovery, development and delivery of novel biologics for autoimmune disorders, cancer and infectious diseases, has elected Paulo Costa to its board as an independent director. Mr Costa, who has more than 35 years' experience in operations and commercialisation in the pharmaceutical industry, is the former president and CEO of Novartis US.


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts